COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study

It has been suggested that cancer patients are at higher risk of contracting COVID-19 and at higher risk of developing a severe form of the disease and fatality. This study’s objectives were to measure the excess risk of mortality and morbidity of patients with cancer among patients hospitalized for...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Julien Péron, Tristan Dagonneau, Anne Conrad, Fanny Pineau, Sara Calattini, Gilles Freyer, David Perol, Christophe Sajous, Maël Heiblig
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	COVID-19 cancer matched cohort study mortality prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b0a6b77b170c4cfc8fe65acb09b59712
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b0a6b77b170c4cfc8fe65acb09b59712
record_format	dspace
spelling	oai:doaj.org-article:b0a6b77b170c4cfc8fe65acb09b597122021-11-11T15:27:03ZCOVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study10.3390/cancers132152832072-6694https://doaj.org/article/b0a6b77b170c4cfc8fe65acb09b597122021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5283https://doaj.org/toc/2072-6694It has been suggested that cancer patients are at higher risk of contracting COVID-19 and at higher risk of developing a severe form of the disease and fatality. This study’s objectives were to measure the excess risk of mortality and morbidity of patients with cancer among patients hospitalized for a SARS-CoV-2 infection, and to identify factors associated with the risk of death and morbidity among cancer patients. All first cancer patients hospitalized for COVID-19 in the two main hospitals of the Lyon area were included. These patients were matched based on age, gender, and comorbidities with non-cancer control patients. A total of 108 cancer patients and 193 control patients were included. The severity at admission and the symptoms were similar between the two groups. The risk of early death was higher among cancer patients, while the risk of intubation, number of days with oxygen, length of stay in ICU, and length of hospital stay were reduced. The main factors associated with early death among cancer patients was the severity of COVID-19 and the number of previous chemotherapy lines. The outcomes appear to be driven by the severity of the infection and therapeutic limitations decided at admission.Julien PéronTristan DagonneauAnne ConradFanny PineauSara CalattiniGilles FreyerDavid PerolChristophe SajousMaël HeibligMDPI AGarticleCOVID-19cancermatched cohort studymortalityprognosisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5283, p 5283 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 cancer matched cohort study mortality prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	COVID-19 cancer matched cohort study mortality prognosis Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Julien Péron Tristan Dagonneau Anne Conrad Fanny Pineau Sara Calattini Gilles Freyer David Perol Christophe Sajous Maël Heiblig COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
description	It has been suggested that cancer patients are at higher risk of contracting COVID-19 and at higher risk of developing a severe form of the disease and fatality. This study’s objectives were to measure the excess risk of mortality and morbidity of patients with cancer among patients hospitalized for a SARS-CoV-2 infection, and to identify factors associated with the risk of death and morbidity among cancer patients. All first cancer patients hospitalized for COVID-19 in the two main hospitals of the Lyon area were included. These patients were matched based on age, gender, and comorbidities with non-cancer control patients. A total of 108 cancer patients and 193 control patients were included. The severity at admission and the symptoms were similar between the two groups. The risk of early death was higher among cancer patients, while the risk of intubation, number of days with oxygen, length of stay in ICU, and length of hospital stay were reduced. The main factors associated with early death among cancer patients was the severity of COVID-19 and the number of previous chemotherapy lines. The outcomes appear to be driven by the severity of the infection and therapeutic limitations decided at admission.
format	article
author	Julien Péron Tristan Dagonneau Anne Conrad Fanny Pineau Sara Calattini Gilles Freyer David Perol Christophe Sajous Maël Heiblig
author_facet	Julien Péron Tristan Dagonneau Anne Conrad Fanny Pineau Sara Calattini Gilles Freyer David Perol Christophe Sajous Maël Heiblig
author_sort	Julien Péron
title	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
title_short	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
title_full	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
title_fullStr	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
title_full_unstemmed	COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study
title_sort	covid-19 presentation and outcomes among cancer patients: a matched case-control study
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/b0a6b77b170c4cfc8fe65acb09b59712
work_keys_str_mv	AT julienperon covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT tristandagonneau covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT anneconrad covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT fannypineau covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT saracalattini covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT gillesfreyer covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT davidperol covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT christophesajous covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy AT maelheiblig covid19presentationandoutcomesamongcancerpatientsamatchedcasecontrolstudy
_version_	1718435328249823232

COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study

Ejemplares similares